View more in
Cancer

Iomab-B Continues to Showcase Impressive Bone Marrow Transplant and Engraftment Rate in Relapsed/Refractory AML

onclive.com
 2021-06-15

Cover picture for the articleIodoine apamistamab, a radiotherapy that targets CD45-expressing cells, demonstrated a 100% bone marrow transplant and engraftment rate in patients with relapsed/refractory acute myeloid leukemia vs 18% for those who received a physician’s choice of salvage treatment. Iodoine (I-131) apamistamab (Iomab-B), a radiotherapy that targets CD45-expressing cells, demonstrated a 100% bone...

www.onclive.com

Comments / 0

Comments / 0